Abstract
Recruitment of patients for clinical trials is an area ready for innovation. At a time when there is measurable interest and support from industry sponsoring clinical trials in the glomerular disease space, connecting the right patients to the right trials as efficiently as possible is of great import. Harnessing data from electronic health records (EHRs) to streamline and personalize clinical trial recruitment using computable phenotypes has the potential to decrease the time and money associated with clinical trial setup. Indeed, global spending on clinical trial technology and services is expected to reach $69 billion per year by 2025.3 EHR-powered analytic tools are already commercialized for the purposes of protocol feasibility, cohort analysis, and study site identification.